These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18754878)

  • 1. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Ohkawa K; Miyagi T; Hiramatsu N; Kanto T; Kasugai T; Katayama K; Kato M; Hayashi N
    Cancer Sci; 2008 Aug; 99(8):1643-9. PubMed ID: 18754878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system.
    Morisaki T; Onishi H; Koya N; Kiyota A; Tanaka H; Umebayashi M; Ogino T; Nagamatsu I; Katano M
    Anticancer Res; 2011 Jul; 31(7):2505-10. PubMed ID: 21873167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma.
    Kohga K; Tatsumi T; Tsunematsu H; Aono S; Shimizu S; Kodama T; Hikita H; Yamamoto M; Oze T; Aketa H; Hosui A; Miyagi T; Ishida H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Cancer Immunol Immunother; 2012 Sep; 61(9):1425-32. PubMed ID: 22302133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.
    Cadoux M; Caruso S; Pham S; Gougelet A; Pophillat C; Riou R; Loesch R; Colnot S; Nguyen CT; Calderaro J; Celton-Morizur S; Guerra N; Zucman-Rossi J; Desdouets C; Couty JP
    J Hepatol; 2021 Jun; 74(6):1386-1397. PubMed ID: 33484773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
    Tong HV; Song le H; Hoan NX; Cuong BK; Sy BT; Son HA; Quyet D; Binh VQ; Kremsner PG; Bock CT; Velavan TP; Toan NL
    BMC Infect Dis; 2015 Jan; 15():25. PubMed ID: 25626490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.
    Li JJ; Pan K; Gu MF; Chen MS; Zhao JJ; Wang H; Liang XT; Sun JC; Xia JC
    Chin J Cancer; 2013 Mar; 32(3):141-8. PubMed ID: 22704489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.
    Shin SK; Oh S; Chun SK; Ahn MJ; Lee SM; Kim K; Kang H; Lee J; Shin SP; Lee J; Jung YK
    J Gastroenterol Hepatol; 2024 Sep; 39(9):1717-1727. PubMed ID: 38800890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.
    Dambrauskas Z; Svensson H; Joshi M; Hyltander A; Naredi P; Iresjö BM
    Int J Oncol; 2014 Jan; 44(1):99-104. PubMed ID: 24173243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
    Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
    J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
    Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
    Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.
    Kato N; Tanaka J; Sugita J; Toubai T; Miura Y; Ibata M; Syono Y; Ota S; Kondo T; Asaka M; Imamura M
    Leukemia; 2007 Oct; 21(10):2103-8. PubMed ID: 17625602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.
    Kohga K; Takehara T; Tatsumi T; Ishida H; Miyagi T; Hosui A; Hayashi N
    Hepatology; 2010 Apr; 51(4):1264-73. PubMed ID: 20099300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer.
    Okita R; Yukawa T; Nojima Y; Maeda A; Saisho S; Shimizu K; Nakata M
    Cancer Immunol Immunother; 2016 May; 65(5):499-509. PubMed ID: 26940474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.
    Ashiru O; Boutet P; Fernández-Messina L; Agüera-González S; Skepper JN; Valés-Gómez M; Reyburn HT
    Cancer Res; 2010 Jan; 70(2):481-9. PubMed ID: 20068167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.